Alfred F. Altomari's Insider Trades & SAST Disclosures

Alfred F. Altomari's most recent trade in Insmed Inc was a trade of 13,162 Common Stock done . Disclosure was reported to the exchange on May 13, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Insmed Inc
Alfred F. Altomari Director 13 May 2024 13,162 69,495 (0%) 0% - Common Stock
Agile Therapeutics Inc
Alfred F. Altomari Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2023 37,500 38,786 (0%) 0% 0 Common Stock
Agile Therapeutics Inc
Alfred F. Altomari Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2023 12,500 12,500 - - Employee Stock Option (Right to Buy)
Agile Therapeutics Inc
Alfred F. Altomari Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2023 8,963 47,749 (0%) 0% 0 Common Stock
Insmed Inc
Alfred F. Altomari Director 11 May 2023 13,192 56,333 (0%) 0% - Common Stock
Agile Therapeutics Inc
Alfred F. Altomari Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2022 30,000 30,000 - - Employee Stock Option (Right to Buy)
Agile Therapeutics Inc
Alfred F. Altomari Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.45 per share. 26 Aug 2022 50,000 64,343 (0%) 0% 0.5 22,500 Common Stock
Insmed Inc
Alfred F. Altomari Director 11 May 2022 14,645 43,141 (0%) 0% - Common Stock
Agile Therapeutics Inc
Alfred F. Altomari Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2022 675,000 675,000 - - Employee Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades